Clinical Trials Directory

Trials / Unknown

UnknownNCT02627209

The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis

Non-infectious and Infectious Uveitis Diagnosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
280 (estimated)
Sponsor
Ozlem Sahin · Academic / Other
Sex
All
Age
9 Years – 86 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the significance of differences in serum angiotensin converting enzyme and lysozyme levels of patients with ocular involvement of other autoimmune inflammatory and infectious diseases.

Detailed description

Increased serum levels of angiotensin converting enzyme and lysozyme are considered as inflammatory markers for diagnosis of sarcoidosis which is an autoimmune inflammatory disease. Sarcoidosis, ankylosing spondylitis and Behcet's disease are the most common autoimmune inflammatory diseases involving the eye. Elevated serum angiotensin converting enzyme levels have also been reported in tuberculosis. Syphilis and tuberculosis are the most common infectious diseases involving the eye.

Conditions

Interventions

TypeNameDescription
OTHERspectrophotometric assaymeasurement of enzyme activity in the serum
OTHERradial immunodiffusionmeasurement of the precipitated ring diameters showing enzyme activity in the serum

Timeline

Start date
2014-06-01
Primary completion
2016-02-01
Completion
2017-01-01
First posted
2015-12-10
Last updated
2015-12-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02627209. Inclusion in this directory is not an endorsement.